The board of the international Gavi vaccines alliance has approved the establishment of an innovative financing mechanism that will be used to build up a sustainable vaccine manufacturing industry in Africa, as part of wider plans to make the continent more self-sufficient and resilient in the face of future health emergencies.
‘Historic’ New Funding Mechanism To Boost African Vaccine Production
Up to $1bn in incentive and milestone payments is to be offered to manufacturers over a 10-year period, focusing on priority antigens and diseases.
